New drug permission has been granted to Moderna, the first internationally developed vaccine. This new drug permission is for restricted use: Dr. VK Paul, Member-Health, Niti Aayog pic.twitter.com/c84VWDL4GZ
Patients across 11 states have been found to be infected by the Delta-Plus variant of the coronavirus. Still, authorities say it is too early to tell whether it poses a significant threat like the Delta strain that drove the devastating second wave, swamping the healthcare system and overwhelming crematoriums.
The central government however, classified the Delta Plus as a “Variant of Concern”, which is more infectious and resistant to treatment. That’s the same degree of threat as the Delta mutation.
Tests are being conducted to check the effectiveness of the vaccines available in India — AstraZeneca’s Covishield and Bharat Biotech’s Covaxin — against the new variant.
